IL-10 Autoantibodies May Drive Inflammatory Bowel Disease in a Subset of Patients
TL;DR
A 2026 NEJM study analyzing data from more than 4,900 people with inflammatory bowel disease found that about 3.5% carry autoantibodies that block interleukin-10, effectively removing an anti-inflammatory brake and potentially driving disease in this subset; the autoantibibody presence is linked to the HLA-DRB1*01:03 variant, suggesting possibilities for early genetic testing and more targeted, mechanism-based therapies.
Topics:healthscience#autoantibodies#hla-drb10103#inflammatory-bowel-disease#interleukin-10#personalized-medicine#science
- One underlying cause of inflammatory bowel disease pinpointed in new study Live Science
- Scientists Uncover Cause of Inflammatory Bowel Disease Solving Decades-Old Mystery SciTechDaily
- Scientists Solve a 30-Year Mystery Behind Inflammatory Bowel Disease ScienceAlert
- Genetic marker may flag severe IBD earlier in some patients Medical Xpress
- Cell-type-resolved genetic variation shapes inflammatory bowel disease risk Nature
Want the full story? Read the original reporting
Read on Live Science